Comments
Loading...
Genprex (NASDAQ:GNPX) Stock Quotes, Forecast and News Summary
Genprex Stock (NASDAQ: GNPX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genprex (GNPX) stock?
You can purchase shares of Genprex (NASDAQ:GNPX) through any online brokerage.
Who are Genprex (GNPX) competitors?
Other companies in Genprex’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO) and Immuron (NASDAQ:IMRN).
What is the forecast, or price target, for Genprex (GNPX) stock?
Genprex has a consensus price target of $6.50.
What is the current price for Genprex (GNPX)?
The stock price for Genprex (NASDAQ: GNPX) is $0.91 last updated January 2, 2025 at 12:54 PM EST.
Does Genprex (GNPX) pay a dividend?
There are no upcoming dividends for Genprex.
When is Genprex (NASDAQ:GNPX) reporting earnings?
Genprex’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Genprex (GNPX) going to split?
There is no upcoming split for Genprex.
What sector and industry does Genprex (GNPX) operate in?
Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.